Theranostics 13.3
Impact Factor
  • Home
  • Aims & Scope
  • Editorial Board
  • For Authors
  • Submit Manuscript
  • Login
  • Contact
  • Account
  • Issue 11; 2026
  • Issue 10; 2026
  • Issue 9; 2026
  • Issue 8; 2026
  • Issue 7; 2026
  • Volume 16; 2026
  • Advance Articles
  • Past Issues
  • Cover Images
  • Cover Suggestion
  • Index & Coverage
  • Special Issues

Nanotheranostics

International Journal of Biological Sciences

International Journal of Medical Sciences

Journal of Cancer

open access Global reach, higher impact

PubMed Central

Theranostics
Archive of Vols. 1-16; 2011-2026

Volume 16; 2026 v.16(1) v.16(2) v.16(3) v.16(4) v.16(5) v.16(6) v.16(7)
  v.16(8) v.16(9) v.16(10) v.16(11)    
Volume 15; 2025 v.15(1) v.15(2) v.15(3) v.15(4) v.15(5) v.15(6) v.15(7)
  v.15(8) v.15(9) v.15(10) v.15(11) v.15(12) v.15(13) v.15(14)
  v.15(15) v.15(16) v.15(17) v.15(18)    
Volume 14; 2024 v.14(1) v.14(2) v.14(3) v.14(4) v.14(5) v.14(6) v.14(7)
  v.14(8) v.14(9) v.14(10) v.14(11) v.14(12) v.14(13) v.14(14)
  v.14(15) v.14(16) v.14(17) v.14(18) v.14(19)   
Volume 13; 2023 v.13(1) v.13(2) v.13(3) v.13(4) v.13(5) v.13(6) v.13(7)
  v.13(8) v.13(9) v.13(10) v.13(11) v.13(12) v.13(13) v.13(14)
  v.13(15)       
Volume 12; 2022 v.12(1) v.12(2) v.12(3) v.12(4) v.12(5) v.12(6) v.12(7)
  v.12(8) v.12(9) v.12(10) v.12(11) v.12(12) v.12(13) v.12(14)
  v.12(15) v.12(16) v.12(17) v.12(18)    

Other volumes: 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

 

 v16i10
Issue 10 • Vol. 16 • 2026
 v16i9
Issue 9 • Vol. 16 • 2026
 v16i8
Issue 8 • Vol. 16 • 2026
 v16i7
Issue 7 • Vol. 16 • 2026
 v16i6
Issue 6 • Vol. 16 • 2026
 v16i5
Issue 5 • Vol. 16 • 2026
 v16i4
Issue 4 • Vol. 16 • 2026
 v16i3
Issue 3 • Vol. 16 • 2026
 v16i2
Issue 2 • Vol. 16 • 2026
 v16i1
Issue 1 • Vol. 16 • 2026
 v15i18
Issue 18 • Vol. 15 • 2025
 v15i17
Issue 17 • Vol. 15 • 2025

More cover images ...

Popup Image

©2026 Ivyspring International Publisher. All rights reserved.
Open access content is subject to applicable licences. By accessing or using this platform, you agree to our Terms of Use.